tetano
Editor, Senior Moderator
BMC Infect Dis
. 2026 Aug 12;26(1):1967.
doi: 10.1186/s12879-026-14169-7.
Cheyenne C E van Hagen # 1 2 , Elizabeth N Mutubuki # 3 4 , Siméon de Bruijn 3 , Eric R A Vos 3 , Gerco den Hartog 3 5 , Fiona R M van der Klis 3 , Cees C van den Wijngaard 3 , Hester E de Melker 3 , Albert Jan van Hoek 3
Affiliations Expand
Background: While previous population-based studies have assessed post-acute sequelae after coronavirus disease 2019 (COVID-19), none have investigated health-related quality of life (HRQoL) and (extreme) fatigue after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the pre-vaccination era. Using a nationwide seroepidemiological study, we investigated endpoints linked to post-COVID-19 condition in the general Dutch population up to one year after infection, including symptomatic and asymptomatic infections among unvaccinated individuals early in the pandemic.
Methods: Participants that were not (yet) vaccinated and aged ≥ 15 years were selected from the February 2021 round of the PIENTER Corona cohort study. We assessed associations between time since serologically-identified SARS-CoV-2 infection and health utility, mental health, physical health and fatigue. To enable comparison across the full range of each outcome, we defined cut-off points for multivariable logistic regression models at every 5% increment (5-75%) along the cumulative distribution of uninfected individuals.
Results: At the lowest 15% cut-off, significant differences between uninfected (n = 4,569) and infected ≤ 4 months ago (n = 351) were observed for health utility (odds ratio [95% confidence interval]: 1.6 [1.2-2.2]), physical health (1.9 [1.5-2.5]) and fatigue (1.6 [1.3-2.1]), but not for mental health. There were no significant differences between uninfected and infected > 4-12 months ago (n = 327) for all outcomes, with post-hoc analysis showing power to detect differences down to 7%.
Conclusions: In this population-based cohort during the first pandemic year, unvaccinated individuals infected with SARS-CoV-2 ≤ 4 months ago reported poorer health utility and physical health, and more severe fatigue compared to those uninfected. For those infected > 4 and up to 12 months ago statistically significant differences could not be detected in our analysis, suggesting a relatively low post-COVID-19 condition population prevalence up to one year after infection.
Trial registration: NTR8473, 21-03-2020.
Keywords: Fatigue; Health-related quality of life; Mental health; Physical health; Post-covid-19 condition; SARS-CoV-2 infection; Seroepidemiology.
. 2026 Aug 12;26(1):1967.
doi: 10.1186/s12879-026-14169-7.
The impact of SARS-CoV-2 on fatigue and quality of life in the pre-vaccination era: prevalence of post COVID-19 condition up to one year after infection in a Dutch population-based serosurveillance cohort
Cheyenne C E van Hagen # 1 2 , Elizabeth N Mutubuki # 3 4 , Siméon de Bruijn 3 , Eric R A Vos 3 , Gerco den Hartog 3 5 , Fiona R M van der Klis 3 , Cees C van den Wijngaard 3 , Hester E de Melker 3 , Albert Jan van Hoek 3
Affiliations Expand
- PMID: 43004264
- PMCID: PMC13749949
- DOI: 10.1186/s12879-026-14169-7
Abstract
Background: While previous population-based studies have assessed post-acute sequelae after coronavirus disease 2019 (COVID-19), none have investigated health-related quality of life (HRQoL) and (extreme) fatigue after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the pre-vaccination era. Using a nationwide seroepidemiological study, we investigated endpoints linked to post-COVID-19 condition in the general Dutch population up to one year after infection, including symptomatic and asymptomatic infections among unvaccinated individuals early in the pandemic.
Methods: Participants that were not (yet) vaccinated and aged ≥ 15 years were selected from the February 2021 round of the PIENTER Corona cohort study. We assessed associations between time since serologically-identified SARS-CoV-2 infection and health utility, mental health, physical health and fatigue. To enable comparison across the full range of each outcome, we defined cut-off points for multivariable logistic regression models at every 5% increment (5-75%) along the cumulative distribution of uninfected individuals.
Results: At the lowest 15% cut-off, significant differences between uninfected (n = 4,569) and infected ≤ 4 months ago (n = 351) were observed for health utility (odds ratio [95% confidence interval]: 1.6 [1.2-2.2]), physical health (1.9 [1.5-2.5]) and fatigue (1.6 [1.3-2.1]), but not for mental health. There were no significant differences between uninfected and infected > 4-12 months ago (n = 327) for all outcomes, with post-hoc analysis showing power to detect differences down to 7%.
Conclusions: In this population-based cohort during the first pandemic year, unvaccinated individuals infected with SARS-CoV-2 ≤ 4 months ago reported poorer health utility and physical health, and more severe fatigue compared to those uninfected. For those infected > 4 and up to 12 months ago statistically significant differences could not be detected in our analysis, suggesting a relatively low post-COVID-19 condition population prevalence up to one year after infection.
Trial registration: NTR8473, 21-03-2020.
Keywords: Fatigue; Health-related quality of life; Mental health; Physical health; Post-covid-19 condition; SARS-CoV-2 infection; Seroepidemiology.